Michail Shipitsin
Vice President Biomarker Development Acrivon Therapeutics
Seminars
Tuesday 27th January 2026
Panel: Unlocking the Full Potential of Biomarkers to Transform DDR Drug Development
9:30 am
• Exploring the evolving role of biomarkers in DDR therapy, from predictive tools to dynamic response monitors
• Evaluate the challenges of biomarker complexity, standardization, and clinical implementation
• Sharing cross-sector insights on integrating biomarkers into trial design, dosing strategies, and regulatory pathways
